BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 37602601)

  • 1. Management and prevention of corneal graft rejection.
    Mandal S; Maharana PK; Kaweri L; Asif MI; Nagpal R; Sharma N
    Indian J Ophthalmol; 2023 Sep; 71(9):3149-3159. PubMed ID: 37602601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathogenesis of corneal graft rejection.
    Maharana PK; Mandal S; Kaweri L; Sahay P; Lata S; Asif MI; Nagpal R; Sharma N
    Indian J Ophthalmol; 2023 May; 71(5):1733-1738. PubMed ID: 37203024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in corneal graft rejection.
    Yin J
    Curr Opin Ophthalmol; 2021 Jul; 32(4):331-337. PubMed ID: 33989234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal graft rejection.
    Panda A; Vanathi M; Kumar A; Dash Y; Priya S
    Surv Ophthalmol; 2007; 52(4):375-96. PubMed ID: 17574064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of corneal transplant failure: a multicentric study.
    Gómez-Benlloch A; Montesel A; Pareja-Aricò L; Mingo-Botín D; Michael R; Barraquer RI; Alió J
    Acta Ophthalmol; 2021 Sep; 99(6):e922-e928. PubMed ID: 33421330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypothesis of immune privilege of the cornea and pathophysiology of graft rejection].
    Trufanov SV; Subbot AM; Malozhen SA; Krakhmaleva DA
    Vestn Oftalmol; 2016; 132(5):117-124. PubMed ID: 28635736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation.
    Hos D; Matthaei M; Bock F; Maruyama K; Notara M; Clahsen T; Hou Y; Le VNH; Salabarria AC; Horstmann J; Bachmann BO; Cursiefen C
    Prog Retin Eye Res; 2019 Nov; 73():100768. PubMed ID: 31279005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Descemet stripping automated endothelialkeratoplasty (DSAEK) versus repeat penetrating keratoplasty (PKP) to manage eyes with failed corneal graft.
    Khairallah A
    Ann Saudi Med; 2018; 38(1):36-41. PubMed ID: 29419526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study.
    Shi W; Chen M; Xie L; Liu M; Gao H; Wang T; Wu X; Zhao J
    Ophthalmology; 2013 Apr; 120(4):695-702. PubMed ID: 23246118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of corneal graft rejection: current practice patterns of the Cornea Society (2011).
    Kharod-Dholakia B; Randleman JB; Bromley JG; Stulting RD
    Cornea; 2015 Jun; 34(6):609-14. PubMed ID: 25811719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors, clinical presentations, prevention, and treatment of corneal graft rejection].
    Trufanov SV; Subbot AM; Malozhen SA; Salovarova EP; Krakhmaleva DA
    Vestn Oftalmol; 2016; 132(6):108-116. PubMed ID: 28635902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy.
    Nanavaty MA; Wang X; Shortt AJ
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008420. PubMed ID: 24526345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Corneal transplantation].
    Mellin KB
    Zentralbl Chir; 1992; 117(12):695-700. PubMed ID: 1285478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathology of posterior lamellar endothelial keratoplasty graft failure.
    Sbarbaro JA; Eagle RC; Thumma P; Raber IM
    Cornea; 2008 Sep; 27(8):900-4. PubMed ID: 18724151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal graft failure: an update.
    Alio JL; Montesel A; El Sayyad F; Barraquer RI; Arnalich-Montiel F; Alio Del Barrio JL
    Br J Ophthalmol; 2021 Aug; 105(8):1049-1058. PubMed ID: 32788325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-diameter penetrating keratoplasty: indications and outcomes.
    Skeens HM; Holland EJ
    Cornea; 2010 Mar; 29(3):296-301. PubMed ID: 20118782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft rejection in component keratoplasty.
    Deshmukh R; Murthy SI; Rapuano CJ; Vajpayee RB
    Indian J Ophthalmol; 2023 Mar; 71(3):698-706. PubMed ID: 36872664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study.
    Szaflik JP; Major J; Izdebska J; Lao M; Szaflik J
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):307-14. PubMed ID: 26553197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep anterior lamellar keratoplasty using acellular corneal tissue for prevention of allograft rejection in high-risk corneas.
    Li J; Yu L; Deng Z; Wang L; Sun L; Ma H; Chen W
    Am J Ophthalmol; 2011 Nov; 152(5):762-70.e3. PubMed ID: 21803324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft rejection rate and graft failure rate of penetrating keratoplasty (PKP) vs lamellar procedures: a systematic review.
    Akanda ZZ; Naeem A; Russell E; Belrose J; Si FF; Hodge WG
    PLoS One; 2015; 10(3):e0119934. PubMed ID: 25781319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.